Actual Approach to Treatment of Haemophilia A and B in Spain

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 52 人开始时间: 2007年6月最近更新: 2007年12月27日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 52
主要终点: Analyze the clinical and therapeutic approach to treament of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis.

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain.

详细描述

Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis.

Assess haemophilia A or B patient profile, study different kinds of hanitual clinical treatment of haemophilia A and B patients, and estimate the kind of treatment and dosage units used per year in patients under habitual clinical practice conditions.

研究设计

研究类型: Observational
观察模型: Case Only
时间视角: Retrospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Haemophilia A or B patients of any age
•Written informed consent

排除标准

未提供

结局指标

主要结局

Analyze the clinical and therapeutic approach to treament of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis.

时间窗: 3 months

次要结局

Assess haemophilia A or B patient profile, study different kinds of habitual clinical treatment of haemophilia A and B patients, and estimate the dosage units used per year in patients under habitual clinical practice conditions.(3 months)

研究者

发起方

Wyeth is now a wholly owned subsidiary of Pfizer

申办方类型

Industry

相似试验

已完成

不适用

Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in FranceHemophilia A

NCT05450640Hospices Civils de Lyon176

已完成

不适用

Evaluation of the Training Program for Community Pharmacists for Dispensing Emicizumab (HEMLIBRA®) in FranceHemophilia A

NCT05449197Hospices Civils de Lyon363

尚未招募

不适用

Patterns of Hemophilia Care in Assiut Children PatientsHemophilia BHemophilia A

NCT05980377Assiut University60

招募中

不适用

Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)Hemophilia BHemophilia A

NCT06158334Hospices Civils de Lyon400

已完成

3 期

Assessing Experiences With Hemophilia A and B: Patient and Caregiver Interviews

CTRI/2021/08/035630Sanofi Aventis Groupe14